Insulin application

Cell-based vaccines

Efforts are being made to shift from traditional egg-based vaccine production to cell-based methods, which offer faster, more stable production, higher yields, and the potential for multiple vaccines in the same platform. Cell culture technology, using various cell lines including HEK293, offers a more flexible, sterile environment for vaccine production, potentially providing better protection than egg-based vaccines. Recombinant Insulin added to chemically defined media increases viral production in cell-based systems.

Where can I learn more?

For more information visit our case study about influenza virus production.

Visit our case study about supplementation of Recombinant Insulin to insect SF9 cell culture to improve cell growth and baculovirus-driven VLP production.

Discover how to boost your influenza virus and VLP production in our infographic.

Explore other Insulin applications